prescription cannabis made uk biotech firm gw pharmaceuticals set approved canadawe delighted receive qualifying notice health canada look forward receiving regulatory approval sativex canada early part 2005 said gw pharma executive chairman dr geoffrey guythis first time cannabisbased approved anywhere world representing landmark gw pharma patients msthe uk government granted gw pharma licence grow cannabis plant medical research purposesa weeks ago shares gw pharma lost third value uk regulators said wanted evidence drugs benefitsbut canadian authorities said sativex considered approval
